(Q53198368)

12 May 2018

title

Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. (English)

1 reference

12 May 2018

4

Joel Tsevat

1 reference

12 May 2018

author name string

Dinesh Khanna

1

1 reference

12 May 2018

Daniel E Furst

2

1 reference

12 May 2018

Weng Kee Wong

3

1 reference

12 May 2018

Philip J Clements

5

1 reference

12 May 2018

Grace S Park

6

1 reference

12 May 2018

Arnold E Postlethwaite

7

1 reference

12 May 2018

Mansoor Ahmed

8

1 reference

12 May 2018

Shaari Ginsburg

9

1 reference

12 May 2018

Ron D Hays

10

1 reference

12 May 2018

Scleroderma Collagen Type 1 Study Group

11

1 reference

12 May 2018

publication date

3 April 2007

1 reference

12 May 2018

published in

Quality of Life Research

1 reference

12 May 2018

volume

16

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

1083-1092

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s11136-007-9207-3

exact match

0 references

cites work

Measuring health-related quality of life

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11136-007-9207-3

Health values of patients with systemic sclerosis.

21 January 2018

1 reference

12 December 2020

Methods to explain the clinical significance of health status measures

1 reference

12 December 2020

The estimation of a preference-based measure of health from the SF-36.

1 reference

12 December 2020

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Surveying physicians to determine the minimal important difference: implications for sample-size calculation

1 reference

12 December 2020

The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

1 reference

12 December 2020

Defining clinically meaningful change in health-related quality of life.

1 reference

12 December 2020

1 reference

12 December 2020

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study

1 reference

12 December 2020

A comparative review of four preference-weighted measures of health-related quality of life

1 reference

12 December 2020

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

12 December 2020

A comparison of the EQ-5D and SF-6D across seven patient groups

1 reference

12 December 2020

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Reference spirometric values using techniques and equipment that meet ATS recommendations

1 reference

12 December 2020

Systemic sclerosis: hypothesis-driven treatment strategies

1 reference

12 December 2020

Assessing utility values in rheumatoid arthritis: A comparison between time trade-off and the EuroQol

1 reference

12 December 2020

Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument

1 reference

12 December 2020

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study

1 reference

12 December 2020

Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients

1 reference

12 December 2020

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

1 reference

12 December 2020

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study

1 reference

12 December 2020

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

1 reference

12 December 2020

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

1 reference

12 December 2020

Systemic sclerosis (scleroderma) and related disorders: clinical aspects

1 reference

12 December 2020

Measurement of health status. Ascertaining the minimal clinically important difference

1 reference

12 December 2020

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

1 reference

12 December 2020

Methodology for measuring health-state preferences--II: Scaling methods

1 reference

12 December 2020

United States life tables, 2002.

1 reference

12 December 2020

Introducing economic and quality of life measurements into clinical studies

1 reference

12 December 2020

Preferences for health outcomes and cost-utility analysis

1 reference

12 December 2020

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis

1 reference

12 December 2020

Approaches and recommendations for estimating minimally important differences for health-related quality of life measures

1 reference

12 December 2020

Measurement of health state utilities for economic appraisal

1 reference

12 December 2020

A critical look at transition ratings

1 reference

12 December 2020

Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11136-007-9207-3

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018